Sai Life Sciences IPO GMP Today, Sai Life Sciences IPO Grey Market Premium Updates | Sai Life Sciences IPO, Latest target, Opening gain
Sai Life Sciences IPO began on -Dec 11, 2024. It will close on -Dec 13, 2024. The Total IPO Size is ₹3,042.62 Crore Approx. The company set its IPO price is ₹522 to ₹549 per share Per Share. There are three basic categories in Sai Life Sciences IPO Subscription:- 1) Qualified Institutional Buyers. 2) Non-Institutional Investors. 3) Retail.
Incorporated in January 1999, Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.
The company’s business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.
In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.
The company has the following service offerings.
- Capabilities in chemistry, manufacturing, and control(“CMC”)/contract development and manufacturing organisations (“CDMO”).
- CRO services include integrated discovery (“Discovery”) capabilities across biology, chemistry, drug metabolism and pharmacokinetics
As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.
As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.
Competitive Strength:
- As an integrated CRDMO, the company provide a complete platform for discovery, development, and manufacturing.
- CRO services include integrated discovery capabilities across biology, chemistry, and drug metabolism and pharmacokinetics.
- CDMO platform with a diverse mix of commercial and under-development molecules
Sai Life Sciences IPO Details:
| Issuer | Sai Life Sciences IPO | |
| Issue Type | Book Built Issue IPO | |
| Issue Period | Issue Opens: – Dec 11, 2024 | |
| Issue Closes: – Dec 13, 2024 | ||
| Price Brand | ₹522to ₹549 per share | |
| Issue Size | ₹ 3,042.62 Cr | |
| Face Value | ₹1 per share | |
| Market Lot | 27-Shares | |
| Retail (Max) | ₹192,699 | |
| QIB | 50% | |
| HNI | 15% | |
| Retail Individual Bidders | 35% | |
| Listing at | NSE & BSE | |
| ✔️ Apply With | ANGEL Free DEMAT Account | |
| Total Shares | Shares -55,421,123 | |
Sai Life Sciences IPO GMP Rates day by day
Sai Life Sciences IPO Market Lot:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹192,699 |
| S-HNI (Min) | 14 | 378 | ₹207,522 |
| S-HNI (Max) | 67 | 1,809 | ₹993,141 |
| B-HNI (Min) | 68 | 1,836 | ₹1,007,964 |
Sai Life Sciences IPO Date, Allotment & Listing:
| Sai Life Sciences IPO Opening Date: | December 11, 2024 |
| Sai Life Sciences IPO Closing Date: | December 13, 2024 |
| Basis of Allotment: | December 16, 2024 |
| Initiation of Refunds: | December 17, 2024 |
| Credit to Demat Account: | December 17, 2024 |
| Listing Date: | December 18, 2024 |
Sai Life Sciences Limited Financial Information (Restated)
Sai Life Sciences Limited’s revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 | ||||||||||||||||||||||||||||||||||||
| Revenue | 693.35 | 1,494.27 | 1,245.11 | 897.74 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 1,044.75 | 974.34 | 887.29 | 877.76 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 855.69 | 953.99 | 867.43 | 859.17 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 764.49 | 710.16 | 699.23 | 751.32 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
The market capitalization of Sai Life Sciences IPO is Rs 11418.63 Cr.
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| P/BV | 10.18 |
| PAT Margin (%) | 5.65 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.34 | 2.69 |
| P/E (x) | 126.42 | 203.82 |
Objects of the Issue (Sai Life Sciences IPO Objectives)
- Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company and
- General corporate purposes
Sai Life Sciences IPO ALLOTMENT STATUS
How to Apply for Sai Life Sciences IPO?
If you’re a new investor Open a DEMAT Account for free with Angel One and build wealth with the best stock choices. Join a 1 million+ family of happy customers.
How to Apply Sai Life Sciences IPO through Zerodha?
Log in to the Console in the Zerodha Website or Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Sai Life Sciences”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open a Demat Account with Zerodha.
How to Apply Sai Life Sciences IPO through Upstox?
Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Sai Life Sciences”. Click on the Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – the mandate. Open a Demat Account with Upstox
PARENT COMPANY FOR SHAREHOLDER QUOTA
IPO ALLOTMENT TIPS & TRICKS
Frequently Asked Questions
What is Sai Life Sciences IPO?
Sai Life Sciences IPO is a main-board initial public offering of 55,421,123 – Equity shares of the face value of ₹1 aggregating up to ₹3,042.62 Crores. The issue price of the IPO is ₹522 to ₹549 Per Equity Share. The minimum order quantity is -27 Shares per application and the offer type is Book Built Issue. The IPO opens on –Dec 11, 2024 and closes on –Dec 13, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Sai Life Sciences IPO opens on –Dec 11, 2024 and closes on –Dec 13, 2024.
How to apply for Sai Life Sciences IPO?
You can apply in Sai Life Sciences IPO online using either UPI or ASBA as payment method . Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd and Iifl Securities Ltd are the book running lead managers of the Sai Life Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
When Sai Life Sciences IPO allotment?
The finalization of Basis of Allotment for Sai Life Sciences IPO will be done on –Dec 16, 2024 and the allotted shares will be credited to your demat account by –Dec 17, 2024.
Check the Sai Life Sciences IPO allotment status.
When is Sai Life Sciences IPO listing date?
The Sai Life Sciences IPO listing date is not yet announced. The tentative date of Sai Life Sciences IPO listing is –Dec 18, 2024.
What is the lot size of Sai Life Sciences IPO?
Sai Life Sciences lot size is 27 Shares and the minimum order quantity is 1 Share.